Alpha Teknova

TKNO · NASDAQ

$7.39+$0.59 (+8.68%)TodayMarket closed · Oct 20, 7:59 PM ET

Prev close $6.80

TKNO analyst rating

BuyConsensus of 4 analysts over the last 12 months. 100% rate it a buy.

Strong buy0
Buy4
Hold0
Underperform0
Sell0

12-month price target · 8 analysts

Average $9.18 (+24.2% upside)

Low: $7.07
Now: $7.39
High: $12.60

Upgrades and downgrades

The latest rating actions, newest first

TKNO analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
TD Cowen	Oct 13, 2026	Maintains	Buy	$7.00 → $11.00	68%
Jefferies	Sep 17, 2026	Initiates	Buy	$9.00	67%
BTIG	Aug 11, 2026	Upgrade	Neutral → Buy	$8.00	54%
Roth Capital	Aug 5, 2026	Initiates	Buy	$7.00	36%

The case for and against

Updated Nov 29, 2024

Bull case

Alpha Teknova Inc has demonstrated significant financial strength, as evidenced by a sequential gross margin increase of 680 basis points, reflecting the operational leverage in its business model. The company has successfully expanded its Lab Essentials customer base, rising from 2,829 at the end of 2023 to 2,913 year-to-date, indicating robust demand and customer engagement. Additionally, Alpha Teknova's confidence in achieving its fiscal year 2024 revenue guidance is bolstered by improved market conditions, enhanced manufacturing efficiency, and strong performance in both clinical and operational segments.

Bear case

Alpha Teknova Inc. is facing a challenging financial outlook due to anticipated declines in Clinical Solutions revenue for 2024, despite an increase in customer count. The company's planned investments in manufacturing, sales, and R&D are expected to lead to operating losses in the near term, with recent performance indicating higher general and administrative expenses than initially estimated. Additionally, potential issues with acquisitions and compliance with debt covenants pose risks that could further impact profitability and core operations.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.